DYN vs. SOFI

Last updated Apr 1, 2026

Compare and contrast key facts about Dyne Therapeutics, Inc. (DYN) and SoFi Technologies, Inc. (SOFI).

Performance

DYN vs. SOFI - Performance Comparison

The chart below illustrates the hypothetical performance of a $10,000 investment in Dyne Therapeutics, Inc. (DYN) and SoFi Technologies, Inc. (SOFI). The values are adjusted to include any dividend payments, if applicable.

DYN vs. SOFI - Yearly Performance Comparison

	2026 (YTD)	2025	2024	2023	2022	2021	2020
DYN Dyne Therapeutics, Inc.	-7.31%	-16.98%	77.14%	14.75%	-2.52%	-43.38%	4.17%
SOFI SoFi Technologies, Inc.	-39.34%	70.00%	54.77%	115.84%	-70.84%	27.09%	18.70%

Fundamentals

EPS DYN : -$3.32 SOFI : $0.38
Total Revenue (TTM) DYN : $0.00 SOFI : $4.36B
Gross Profit (TTM) DYN : $0.00 SOFI : $2.56B
EBITDA (TTM) DYN : -$433.40M SOFI : $818.24M

Returns By Period

In the year-to-date period, DYN achieves a -7.31% return, which is significantly higher than SOFI's -39.34% return.

DYN

• 1D: 6.09%
• 1M: 16.07%
• YTD: -7.31%
• 6M: 43.32%
• 1Y: 73.33%
• 3Y*: 16.32%
• 5Y*: 2.61%
• 10Y*: —

SOFI

• 1D: 4.82%
• 1M: -10.59%
• YTD: -39.34%
• 6M: -39.89%
• 1Y: 36.54%
• 3Y*: 37.79%
• 5Y*: -1.66%
• 10Y*: —

*Multi-year figures are annualized to reflect compound growth (CAGR)

Return for Risk

DYN vs. SOFI — Risk / Return Rank

Compare risk-adjusted metric ranks to identify better-performing investments over the past 12 months.

DYN

DYN Risk / Return Rank: 69
DYN Sharpe Ratio Rank: 69
DYN Sortino Ratio Rank: 72
DYN Omega Ratio Rank: 71
DYN Calmar Ratio Rank: 68
DYN Martin Ratio Rank: 64

SOFI

SOFI Risk / Return Rank: 60
SOFI Sharpe Ratio Rank: 64
SOFI Sortino Ratio Rank: 62
SOFI Omega Ratio Rank: 59
SOFI Calmar Ratio Rank: 57
SOFI Martin Ratio Rank: 60

The rank (0–100) shows how this investment's returns compare to the risk taken. Higher = better. Based on the past 12 months of data, combining Sharpe, Sortino, and other metrics used by quantitative funds and institutional investors.

DYN vs. SOFI - Risk-Adjusted Trends Comparison

This table presents a comparison of risk-adjusted performance metrics for Dyne Therapeutics, Inc. (DYN) and SoFi Technologies, Inc. (SOFI). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.

	DYN	SOFI	Difference
Sharpe ratio Return per unit of total volatility	0.81	0.61	+0.19
Sortino ratio Return per unit of downside risk	1.70	1.20	+0.50
Omega ratio Gain probability vs. loss probability	1.22	1.15	+0.08
Calmar ratio Return relative to maximum drawdown	1.31	0.64	+0.66
Martin ratio Return relative to average drawdown	2.57	1.74	+0.84
Data is calculated on a 1-year rolling basis and updated daily. The trend shows the change in the indicator over the past month.

DYN vs. SOFI - Sharpe Ratio Comparison

The current DYN Sharpe Ratio is 0.81, which is higher than the SOFI Sharpe Ratio of 0.61. The chart below compares the historical Sharpe Ratios of DYN and SOFI, offering insights into how both investments have performed under varying market conditions. These values are calculated using daily returns over the previous 12 months.

Sharpe Ratios by Period

	DYN	SOFI	Difference
Sharpe Ratio (1Y) Calculated over the trailing 1-year period	0.81	0.61	+0.19
Sharpe Ratio (5Y) Calculated over the trailing 5-year period	0.03	-0.02	+0.06
Sharpe Ratio (All Time) Calculated using the full available price history	-0.06	0.11	-0.17

Correlation

The correlation between DYN and SOFI is 0.27, which is considered to be low. This implies their price changes are not closely related. A low correlation is generally favorable for portfolio diversification, as it helps to reduce overall risk by spreading it across multiple assets with different performance patterns.

Dividends

DYN vs. SOFI - Dividend Comparison

Neither DYN nor SOFI has paid dividends to shareholders.

Tickers have no history of dividend payments

Drawdowns

DYN vs. SOFI - Drawdown Comparison

The maximum DYN drawdown since its inception was -85.52%, roughly equal to the maximum SOFI drawdown of -83.32%. Use the drawdown chart below to compare losses from any high point for DYN and SOFI.

Drawdown Indicators

	DYN	SOFI	Difference
Max Drawdown Largest peak-to-trough decline	-85.52%	-83.32%	-2.20%
Max Drawdown (1Y) Largest decline over 1 year	-44.65%	-52.96%	+8.31%
Max Drawdown (5Y) Largest decline over 5 years	-85.52%	-82.00%	-3.52%
Current Drawdown Current decline from peak	-61.46%	-50.70%	-10.76%
Average Drawdown Average peak-to-trough decline	-50.38%	-51.35%	+0.97%
Ulcer Index Depth and duration of drawdowns from previous peaks	22.66%	19.57%	+3.09%

Volatility

DYN vs. SOFI - Volatility Comparison

Dyne Therapeutics, Inc. (DYN) has a higher volatility of 29.31% compared to SoFi Technologies, Inc. (SOFI) at 10.57%. This indicates that DYN's price experiences larger fluctuations and is considered to be riskier than SOFI based on this measure. The chart below showcases a comparison of their rolling one-month volatility.

Volatility by Period

	DYN	SOFI	Difference
Volatility (1M) Calculated over the trailing 1-month period	29.31%	10.57%	+18.74%
Volatility (6M) Calculated over the trailing 6-month period	63.83%	42.01%	+21.82%
Volatility (1Y) Calculated over the trailing 1-year period	91.78%	59.89%	+31.89%
Volatility (5Y) Calculated over the trailing 5-year period, annualized	79.40%	67.12%	+12.28%
Volatility (10Y) Calculated over the trailing 10-year period, annualized	79.22%	72.33%	+6.89%

Financials